$3.84 -0.12 (-3.03%)
2/10/2012 4:00 PM

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)

CAPS Rating: 2 out of 5

A biotechnology company, which designs, optimizes and develops novel drugs that block key enzymes involved in cancer, cardiovascular diseases, autoimmune diseases, and viral infections.

Featured Broker Partners


Advertisement